The impact of OxA treatment on chemoresistant tumors, on the expression of various proteins such as Nrf2, p-eIF2α, ATF4, PolQ, FoxM1, and Bcl2, which are involved in cancer chemoresistance (34–38), is not shown. This evidence concerns the gene FOXM1 and cancer.